🚨 Last Chance! Early‑bird rates for #NYValves2026 end TODAY at 1:59 PM EST — don’t miss out!

🗽 Live Cases 📊 Breakthrough Trials 🫀 Innovative Techniques

👉 https://ow.ly/Mq7C50YkzoB

#CardioSky #MedSky #structuralheartdisease

Get an exclusive look at the expert-led sessions, live cases, and latest innovations that make #NYValves2026 the premier summit in structural heart care! 🫀

Explore the Program at a Glance today 👉 https://ow.ly/hFxN50Y8sBO

#structuralheartdisease #CardioSky #MedSky

Fu Wai Hospital successfully performed the TMVIV (Mitral Valve-in-Valve) minimally invasive procedure, saving an 83-year-old critical patient. Transfemoral access, no open chest, heart beating autonomously. #TMVIV #StructuralHeartDisease #MinimallyInvasive #FuWaiHospital

⏳ Last days to save! Early-bird pricing for #NYValves2025 ends 4/16 at 11:59 PM EDT!

Don’t miss your chance to be part of a dynamic experience where innovation, collaboration, & cutting-edge science redefine what’s possible in #structuralheartdisease. #CardioSky www.nyvalvesconference.com/register

🔊 Public Comment Period Now Open! SCAI’s upcoming position statement explores the growing role of #ICE imaging in #StructuralHeartDisease interventions. Share your feedback by April 21! 🏥💬

🔗 scai.org/publications...

#StructuralHeart #InterventionalCardiology #CardioSky

Feasibility of a Systematic Same-Day Discharge Approach After Elective Mitral Transcatheter Edge-to-Edge Repair Mitral transcatheter edge-to-edge repair (M-TEER) is usually performed in the setting of a hospitalization. Some recent data suggest the safety of a same-day discharge (SDD) approach after M-TEER, but...

📖 A high-volume, single-center study evaluated the feasibility of same-day discharge after elective M-TEER. Results indicate it may be safe in a select patient population. Read more here 👉 www.structuralheartjournal.org/article/S247... #CardioSky #CardioResearch #structuralheartdisease

2024 Core Curriculum for percutaneous SHD interventions by EAPCI aims to fill the training gap in #structuralheartdisease management. Developed with EACVI & WG CVS of ESC, it sets a foundation for future SHD training across specialties. Learn more: ow.ly/xORJ50Ua9YX #cardiosky

Day 1 of Controversies was filled with great discussions on a wide range of topics from #Atherosclerosis #StructuralHeartDisease #Hypertension #ClinicalTrials #AI
We can’t wait for what day 2 will bring.